| Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -. | |
| | |
MedLine Citation:
|
PMID: 20234098 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The purpose of this study was to explore the effect of lifestyle modification, mainly daily aerobic exercise, on coronary atherosclerosis in patients with coronary artery disease (CAD). METHODS AND RESULTS: A 6-month prospective observational study was conducted with 84 CAD patients receiving pravastatin treatment in order to evaluate the relationship between lifestyle modification, in particular aerobic exercise, and plaque volume as assessed by intravascular ultrasound (IVUS). Lifestyle during the study period was assessed by the-lifestyle modification score. A significant decrease in plaque volume by 12.9% was observed after 6 months of pravastatin therapy (P<0.0001 vs baseline). The change in plaque volume correlated with the change in the serum level of high-density lipoprotein cholesterol (HDL-C) (r=-0.549, P<0.0001), non-HDL-C (r=0.248, P=0.03), low-density lipoprotein cholesterol/HDL-C (r=0.505, P<0.0001), apolipoprotein (apo) A-1 (r=-0.335, P=0.007) and apoB/apoA-1 (r=0.335, P=0.007), and lifestyle modification score (r=-0.616, P<0.0001). There was a clear positive correlation between a change in the serum HDL-C level and lifestyle modification score. Multivariate regression analysis revealed that the increase in serum HDL-C level and lifestyle modification score were independent predictors of coronary plaque regression. CONCLUSIONS: An appropriate combination of statin therapy and lifestyle modification, in particular, physical activity, may result in coronary plaque regression. This combined treatment strategy, inducing an increase of the serum HDL-C, may contribute to coronary plaque regression. |
| | |
Authors:
|
Shigemasa Tani; Ken Nagao; Takeo Anazawa; Hirofumi Kawamata; Shingo Furuya; Hiroshi Takahashi; Kiyoshi Iida; Michiaki Matsumoto; Takehiko Washio; Narimichi Kumabe; Atsushi Hirayama |
Related Documents
:
|
8827528 - Evidence for electronegativity of plasma high density lipoprotein-3 as one major determ... 1964118 - The effect of a single-circuit weight-training session on the blood biochemistry of unt... 7977088 - Effects of cardiac rehabilitation and exercise training on low-density lipoprotein chol... 2900258 - Nonselective beta-receptor blocker effect on high density lipoprotein cholesterol after... 12000058 - Accuracy of a pretest questionnaire in exercise test protocol selection. 2515328 - Carbon dioxide-heart rate responses during hyperoxia, euoxia, and hypoxia. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't Date: 2010-03-17 |
Journal Detail:
|
Title: Circulation journal : official journal of the Japanese Circulation Society Volume: 74 ISSN: 1347-4820 ISO Abbreviation: Circ. J. Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-05-07 Completed Date: 2010-08-13 Revised Date: 2011-02-18 |
Medline Journal Info:
|
Nlm Unique ID: 101137683 Medline TA: Circ J Country: Japan |
Other Details:
|
Languages: eng Pagination: 954-61 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Nihon University Surugadai Hospital, Tokyo, Japan. tanishigem@yahoo.co.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anticholesteremic Agents / administration & dosage* Cholesterol, HDL / blood* Coronary Artery Disease / blood*, therapy*, ultrasonography Coronary Vessels / ultrasonography Exercise* Female Humans Life Style* Male Middle Aged Pravastatin / administration & dosage* Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
0/Anticholesteremic Agents; 0/Cholesterol, HDL; 81093-37-0/Pravastatin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High index of microcirculatory resistance level after successful primary percutaneous coronary inter...
Next Document: Beta-blocker prescription among Japanese cardiologists and its effect on various outcomes.